Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Two Years, Three Funds, $500MM In AUM Not Rated 5.0 Email Routing List Email & Route  Print Print
Wednesday, August 19, 2020

Two Years, Three Funds, $500MM In AUM

Reported by Katherine Robertson, Editorial Intern

Two years in, the team at New York City-based Defiance ETFs has crossed the $500 million AUM milestone.

Matthew Ross Bielski
Defiance ETFs, LLC
Founder, CEO
"Despite a global pandemic that has generated uncertainties across many sectors, we have continued to bring innovative first-to-market ETFs that are in high demand by both retail and institutional investors," Matt Bielski , Defiance's CEO, stated. They celebrated by ringing the Nasdaq closing bell yesterday.

Earlier this month, the Defiance team unveiled their third ETF, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ). This ETF tracks small to mid-cap biotech companies, or those with a market capitalization of below $5 billion.

Defiance ETFs was founded in 2018 by Bielski after his previous experiences at ProShares, BlackRock, and Direxion. The firm crossed the $100 million AUM line last year.  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

5.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2020
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use